Crataegus rhipidophylla var. rhipidophylla
Crataegus rhipidophylla var. rhipidophylla · Accepted scientific name
Scientific literature: Very Sparse (6 studies) · ★☆☆☆☆
Crataegus rhipidophylla var. rhipidophylla is a botanical species valued for its diverse pharmacological potential across various plant parts, including the fruit, flower, and leaf. Rich in bioactive chemicals such as flavonoids, betulin, and lupeol, its extracts and tinctures serve as potent sources of therapeutic compounds. Research highlights its significant antioxidant and hypocholesterolemic activities, which may help mitigate the effects of oxidative stress. Furthermore, its antiatherosclerotic properties offer promising applications in managing conditions like angina pectoris and dyspnea. Ongoing studies also explore its medicinal relevance in addressing complex issues such as Alzheimer's disease and genotoxic concerns.
- Synonyms
- Crataegus Rosiformis Var. Carpatica · Crataegus Rosiformis F. Rigidula · 31 more
- Common names
- Not available
- Family
- Rosaceae
- Distribution
- Not available
- Plant Parts
- Fruit · Flower
Classification
Common Names
Crataegus rhipidophylla var. rhipidophylla is a distinctive species known by several different common names across various regions. In some areas, it is frequently referred to as begerhagtorn or vanleg begerhagtorn. It also goes by the name siirosuippuorapihlaja, reflecting its unique linguistic identity. Furthermore, the plant is recognized by the names skoghagtorn and spetshagtorn. These diverse naming conventions highlight the widespread presence and cultural recognition of this particular variety.
Sources: Catalogue of Life (COL)
Synonyms
Crataegus rhipidophylla var. rhipidophylla is a complex botanical taxon that is associated with several different scientific names. This variety is recognized by the synonym Crataegus appressidens, illustrating the taxonomic overlap present in the genus. Furthermore, it shares a relationship with Crataegus curvisepala, which encompasses several distinct forms and subspecies. Specifically, it is linked to Crataegus calycina subsp. curvisepala as well as the variety Crataegus curvisepala f. submontana. Finally, the botanical identity of this plant also encompasses the synonym Crataegus curvisepala subsp. carpatica.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Crataegus rhipidophylla var. rhipidophylla is a specialized botanical specimen belonging to the vast kingdom Plantae. Within this kingdom, it is classified under the class Equisetopsida and the order Rosales. This specific variety is a member of the diverse genus Crataegus, which showcases unique morphological traits. Furthermore, it finds its place within the well-known family Rosaceae. Understanding these biological relationships helps researchers better categorize this plant within the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Rosales |
| Family | Rosaceae |
| Genus | Crataegus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Crataegus rhipidophylla var. rhipidophylla exhibits a remarkably wide geographical range that spans multiple continents and diverse climates. Within the Asia-Temperate region, it can be found stretching from the Caucasus and Transcaucasus through Central Asia and Uzbekistan to Western Asia in Türkiye. Its presence also extends into Eastern Europe, where it is documented across the Baltic States. Interestingly, the species reaches far beyond its typical northern habitats to inhabit the Australasia region, specifically in Queensland, Australia. This broad distribution highlights the plant's significant adaptability to varying ecological conditions worldwide.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Crataegus rhipidophylla var. rhipidophylla exhibits a diverse range of biological activities that impact both cardiovascular health and cellular integrity. Research indicates that the plant possesses significant antioxidant properties, which play a crucial role in combating oxidative stress. Furthermore, it demonstrates hypocholesterolemic and antiatherosclerotic effects by regulating cholesterol levels and enhancing LDL-receptor activity. However, studies also caution that the plant's extracts can exhibit genotoxic and mutagenic effects under certain concentrations and experimental conditions. Understanding these complex relationships is essential for evaluating the plant's overall safety and therapeutic potential.
Compounds
Crataegus rhipidophylla var. rhipidophylla contains flavonoids, which are identified as primary constituents in various preparations of the hawthorn plant. These bioactive compounds play a crucial role in the plant's medicinal properties, such as its ability to enhance LDL-receptor activity and manage cholesterol levels. Research suggests that these flavonoids may act synergistically with other constituents to provide significant hypocholesterolemic and antiatherosclerotic effects. Furthermore, the presence of these substances has been linked to myocardial protection by helping to preserve cell membranes during ischemic events. Ultimately, the high flavonoid content makes this species a significant subject of study for cardiovascular health and disease prevention.
Conditions
Crataegus rhipidophylla var. rhipidophylla treats cardiovascular disorders by improving coronary blood flow and increasing blood vessel wall integrity. This plant also treats dyspnea, serving as a traditional medicinal substance for respiratory relief. Its antioxidant properties allow it to treat oxidative stress by reducing inflammation and protecting DNA from damage. Additionally, the extract treats genotoxicity induced by gamma irradiation by significantly decreasing the incidence of micronuclei in cells. Finally, the plant treats AST by lowering serum hepatic enzyme levels during the management of liver disease.
Preparations
Crataegus rhipidophylla var. rhipidophylla is prepared as various extracts to utilize its medicinal properties. Specifically, the plant is processed into a fruit extract that has been studied for its genotoxic and mutagenic effects in cultured cells. It is also prepared as a tincture of Crataegus, which acts as a hypocholesterolemic and antiatherosclerotic drug. Furthermore, the plant is utilized as an alcoholic extract of the berries to provide anti-inflammatory and anti-apoptotic protection against myocardial damage. Finally, aqueous extracts of the plant have been evaluated for their potential antistaphylococcal activity in treating skin infections.
Parts used
Crataegus rhipidophylla var. rhipidophylla is a plant characterized by several distinct anatomical parts. Specifically, the species possesses a fruit, which is often utilized in medicinal extracts for its bioactive properties. In addition to its fruit, the plant also features flowers that contribute to its overall biological profile. The structure is further completed by the presence of leaves, which serve as another key component of the organism. Together, these parts—the fruit, flower, and leaf—make up the essential physical makeup of this variety.